2014
DOI: 10.1111/bjd.13087
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTUREnetwork

Abstract: Ustekinumab showed a better overall drug survival than etanercept, and a trend towards a better overall drug survival than adalimumab. After 1 year, patients reported to be 'happy' in 79% of episodes and 'unhappy' in 21%. We introduced the new concept of 'happy' drug survival because the proportion of on-drug patients with good quality of life is an important indicator for treatment success.

Search citation statements

Order By: Relevance

Paper Sections

Select...
71
19
8
5

Citation Types

20
61
2
13

Year Published

2014
2014
2024
2024

Publication Types

Select...
94
2

Relationship

5
91

Authors

Journals

citations

Cited by 96 publications

(96 citation statements)
references

References 37 publications

20
61
2
13
Order By: Relevance
“…With the current report, we confirmed previously published studies where ustekinumab showed the highest drug survival compared to adalimumab, etanercept, and infliximab . Moreover, we supported the findings by Egeberg et al .…”
Section: Discussionsupporting
confidence: 93%
Exaggerated anticipatory anxiety is common in social anxiety disorder (SAD). Neuroimaging studies have revealed altered neural activity in response to social stimuli in SAD, but fewer studies have examined neural activity during anticipation of feared social stimuli in SAD. The current study examined the time course and magnitude of activity in threat processing brain regions during speech anticipation in socially anxious individuals and healthy controls (HC). Method Participants (SAD n = 58; HC n = 16) underwent functional magnetic resonance imaging (fMRI) during which they completed a 90s control anticipation task and 90s speech anticipation task.
“…With the current report, we confirmed previously published studies where ustekinumab showed the highest drug survival compared to adalimumab, etanercept, and infliximab . Moreover, we supported the findings by Egeberg et al .…”
Section: Discussionsupporting
confidence: 93%
Exaggerated anticipatory anxiety is common in social anxiety disorder (SAD). Neuroimaging studies have revealed altered neural activity in response to social stimuli in SAD, but fewer studies have examined neural activity during anticipation of feared social stimuli in SAD. The current study examined the time course and magnitude of activity in threat processing brain regions during speech anticipation in socially anxious individuals and healthy controls (HC). Method Participants (SAD n = 58; HC n = 16) underwent functional magnetic resonance imaging (fMRI) during which they completed a 90s control anticipation task and 90s speech anticipation task.
“…Our data confirmed previously reported data from several registrybased studies (Brunasso, Puntoni, & Massone, 2012;Iskandar, et al 2015May18;Menting, Sitaram, & Bonnerjee-van der Stok, 2014;van den Reek et al, 2014;Warren et al, 2015). In a retrospective cohort study evaluating tolerability and safety of biological drugs (adalimumab, efalizumab, etanercept, and infliximab) in 108 PsO patients infliximab was significantly associated with a shorter adherence to therapy compared with adalimumab, etanercept, and efalizumab (Brunasso et al, 2012).…”
Section: Discussionsupporting
confidence: 93%
Exaggerated anticipatory anxiety is common in social anxiety disorder (SAD). Neuroimaging studies have revealed altered neural activity in response to social stimuli in SAD, but fewer studies have examined neural activity during anticipation of feared social stimuli in SAD. The current study examined the time course and magnitude of activity in threat processing brain regions during speech anticipation in socially anxious individuals and healthy controls (HC). Method Participants (SAD n = 58; HC n = 16) underwent functional magnetic resonance imaging (fMRI) during which they completed a 90s control anticipation task and 90s speech anticipation task.
“…Consistent with some, but not all, previous studies, we found that drug survival rates for the first and second courses of biologic therapies were comparable ( Menting et al., 2014 , van den Reek et al., 2014b ). However, compared with those studies, our research has important strengths: our sample size was much larger, thereby giving the study more power for the investigation of comparative second-line biologic survival, and we included patients from multiple dermatology centers, thus ensuring high external validity.…”
Section: Discussionsupporting
confidence: 92%
Exaggerated anticipatory anxiety is common in social anxiety disorder (SAD). Neuroimaging studies have revealed altered neural activity in response to social stimuli in SAD, but fewer studies have examined neural activity during anticipation of feared social stimuli in SAD. The current study examined the time course and magnitude of activity in threat processing brain regions during speech anticipation in socially anxious individuals and healthy controls (HC). Method Participants (SAD n = 58; HC n = 16) underwent functional magnetic resonance imaging (fMRI) during which they completed a 90s control anticipation task and 90s speech anticipation task.